PHARMATHEN GLOBAL LTD
Opportunity 55/100 (worth a look), bankability 70/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Company dissolved. Company has been dissolved — it no longer legally exists. Any diligence here is historical only. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: medium (60/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Recent activity
Corporate timeline (32 events)Click to expand
- 2019-01-22📄gazette-dissolved-voluntarygazette · GAZ2(A)
- 2019-01-22🏁Company dissolved
- 2018-11-06📄gazette-notice-voluntarygazette · GAZ1(A)
- 2018-10-29📄dissolution-application-strike-off-companydissolution · DS01
- 2017-10-06📄accounts-with-accounts-type-fullaccounts · AA
- 2017-06-17📄capital-allotment-sharescapital · SH01
- 2017-05-25📄legacycapital · SH20
- 2017-05-25📄capital-statement-capital-company-with-date-currency-figurecapital · SH19
- 2017-05-25⚠️legacyinsolvency · CAP-SS
- 2017-05-25📄resolutionresolution · RESOLUTIONS
- 2017-01-03📄accounts-with-accounts-type-fullaccounts · AA
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2016-09-30📄resolutionresolution · RESOLUTIONS
- 2016-09-29📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-09-27📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2016-05-19📄change-person-director-company-with-change-dateofficers · CH01
- 2016-05-17📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-10-08📄capital-allotment-sharescapital · SH01
- 2015-09-01➕KASTKA, Maximilian Hendrik appointeddirector
- 2015-09-01➕KATSOS, Vassilios appointeddirector
- 2015-09-01➕KATSOU, Eleni appointeddirector
- 2015-07-21➕EVANS, Matthew George appointeddirector
- 2015-04-22🏢Company incorporatedAs PHARMATHEN GLOBAL LTD
- 2015-04-22➕HERSEE, Mark Philip appointeddirector
- 2015-04-22➕ILIA, Stylianos appointeddirector
- 2015-04-22➕STATHOPOULOS, Nikolaos appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- -7 active directors: Broader management team in place — suggests transferable governance.
- +Senior director age: Director aged approximately 61 — approaching natural succession window.
- +No director turnover: Company is 11 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryFounder aged 58+: Senior director is approximately 61. Early succession window.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
2 high ·Company has been dissolved — it no longer legally exists. Any diligence here is historical only.
Evidence: Dissolved on 2019-01-22
Filings relating to insolvency, liquidation, or administration exist in the company's history. Review before proceeding.
Evidence: 2017-05-25: legacy
Group structure
Pharmathen Holding 4 Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Pharmathen Holding 4 Limited Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · SG postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALLIED ACCOUNTANCY LIMITED→ 10708117 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| ALPAC ADVISORY LIMITED→ 11306032 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ALPINE RESORT NANNIES LTD→ 11341309 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AMBER RECLAIM LTD→ 16663660 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMBR LTD→ 12971824 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AML COMPLIANCE EXPERTS LIMITED→ 16293777 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AMPYR IDEA UK LTD→ 15255740 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMWELL SPRING CONSULTING LIMITED→ 12213181 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ANDREW NUNN LIMITED→ 17122944 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ANDY B CONSULTING LTD→ 15586572 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANGEL HUMAN RESOURCES MANAGED SERVICES LIMITED→ 07099466 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ANGELA MALLOY CONSULTANCY LTD→ 11742667 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (0 active · 0 resigned)
Click a director name to see their full track record across all companies.